Business leader

now browsing by category


General Information about Amicus Therapeutics

Amicus Therapeutic is a biopharmaceutical company. This organization was founded in 2002 and it works to combat orphan and rare diseases. Amicus was founded by different venture capital firms who combined their resources. These firms include Radius Ventures, Canaan Partners and New Enterprise Associates. The company is led by three key people which include CEO John Crowley, COO Bradley Campbell and the company’s Chief Financial Officer, Willian Baird.

Amicus Therapeutics is a leading research and treatment facility in the fight against rare diseases. An orphan disease is a condition that is experienced by 200,000 people or fewer within a large population of people. A rare disease is defined by its ability to affect a small percentage of a population. Most rare diseases are genetic and the same is also true for orphan diseases.

The founders of Amicus realize that rare diseases can still negatively impact various ethnic groups and populations from around the world. Diseases such as cystic fibrosis, Lou Gehrig’s disease, Hamburger disease and Tourette’s syndrome falls into the rare and orphan diseases categories. Other diseases such as gigantism and job syndrome are also treated by this medical organization.

Various pharmaceutical treatment options consist of the Chaperone-Advanced Replacement Therapy or CHART. This is a proven enzyme replacement therapy that the founders use to treat people. CHART is the company’s leading treatment drug. It is used for various patients with unique conditions. This company has been helping the medical community to find viable solutions with their efforts in eliminating specific diseases.

Amicus Therapeutics opened up another facility in San Diego, California in 2008. Their original location is in Cranbury, New Jersey. This organization has also acquired Callidus Biopharma and Scioderm. These acquisitions helped Amicus Therapeutics expand its research and treatment options to combat unusual diseases such as Pompe. Amicus Therapeutics brings in a revenue of $18 million per year and is growing in a positive direction.

More here: Twitter, Facebook

Troy McQuagge Receives the One Plant Gold Award C.E.O of the Year Gold

The One Planet Business and Professional Excellence Awards were held in January 2017. Troy McQuagge was among the many winners awarded during the awards. Troy, Chief Executive Officer of USHEALTH Group of Companies, won the Gold Award as the C.E.O of the Year.

One Planet Awards are held to honor professionals who have attained excellence in their line of work. All companies and organizations around the world are eligible to submit their nominations for the awards.

In response to his award, Troy commented that his win was a team effort. The award was a representation of the success of USHEALTH in providing quality healthcare services. USHEALTH Group was also honored with a Gold One Planet Awards.

About Troy McQuagge

Troy McQuagge is a dynamic individual with 30 years of experience in the business world. Troy joined USHEALTH Advisors in 2010, and he serves as the President and Chief Executive Officer since then. USHEALTH Advisors is the marketing group of the group. In this position, Troy has managed to develop the strategic plan for the Company.

After achieving much success in the Company, Troy was promoted to the position of President, Chief Executive Officer and a Member of the USHEALTH Group Board of Directors. Over the first three years, Troy has managed to promote and lead the Company to achieve success.

Throughout his career, Troy has received over 20 awards including the CEO World Awards and the Stevie Awards.

For 11 years, Troy served as the President of Agency Marketing Group at the HealthMarket.

Aside from being an excellent leader, Troy has committed his time to giving back to the community. He has volunteered at HopeKids Dallas, Phoneix, Phoneix New Orlean, and Trinity Habitat for Humanity.

Troy holds a Bachelor of Arts in Legal Studies from the University of Central Florida.

About USHEALTH Group

USHEALTH Group of companies has services that protect Americans families in the present and also in the future. Over 50 years, the Company has developed flexible and secure plans. They have innovative health coverage for all the people regardless of their financial status. It is the ability of the team to understand each client’s needs that have given them success. They believe that all customers are unique and not all the services are suitable for everyone. The different products offered by the Company include PremierChoice, Life Protector, Accident and Income Protectors. USHEALTH Group focuses on providing affordable services and learn more about Troy.

USHEALTH Group offers the services through the USHEALTH Advisors. The Advisors have exceptional experience and knowledge. The Advisors must meet the minimum requirements and have the certifications. USHEALTH Advisors have received different awards because of their excellent services and more information click here.

More visit:

The Carreer Focus And Business Experience Of James Dondero

James Dondero is the president as well as one of the founders of Highland Capital Management. He has been appointed as a member of the Executive Board for the Southern Methodist University. His new position has the benefit of expanding the already strong commitment made by Highland to SMU. The Cox School located at SMU is a large part of Dallas’s business community. There are approximately 100 members on the board who are mainly non-academics. They meet three times each year with the purpose of strategizing about the business school.


Dondero is the Chairman for CCS Medical, Cornerstone Healthcare, the Nexpoint Residential Trust and Nexbank. In addition he is on the board for MGM Studios and Jernigan Capital.


Highland Capital Management is an investment manager registered with the SEC. When combined with their affiliates their assets total $16 billion. Mark Okada and James Dondero founded Highland in 1993. They have become one of the biggest and most experienced credit managers. Their specializations include special-situation private equity, credit hedge funds, credit strategies, collateralized loan obligations and long-only funds.


Highland also deals in emerging markets, alternative investments and natural resources. They offer endowments, fund of funds and public pension plans as well as several other additional services. They are based in Dallas, Texas although they also have offices in Singapore, New York, Seoul and San Paolo.


James Dondero has more than thirty years of experience in equity and credit markets. He has focused mainly on both distressed and high yield investments. Since Highland was founded in 1993 they have become experts in Collateralized Loans the development of credit solutions for retail and institutional investors.


Before Mr. Dondero began Highland he helped with the creation of a subsidiary of GIC called Protective Life. He has experience as a corporate bond analyst and also as a Portfolio manager when he was with American Express. He started his career in 1984 working for Morgan Guaranty as an analyst. Mr. Dondero was educated at the University of Virginia where he graduated with the highest honors. He had a dual major in finances and accounting.